Oncomagnetic device harnesses electromagnetic fields to kill cancer cells
Live Forever Club - 20-Nov-2023Device uses non-invasive magnetic fields to increase ROS levels in cancer cells
Join the club for FREE to access the whole archive and other member benefits.
Associate Professor at Houston Methodist Research Institute
Dr. Helekar's current research program focuses on the development and refinement of two new portable wearable noninvasive magnetic stimulation devices, namely an Oncomagnetic device (OMD) to treat glioblastoma and a neuromodulation device called Transcranial Rotating Permanent Magnet Stimulator (TRPMS) invented by him, the latter in collaboration with Dr. Henning Voss of WMC. Ongoing projects in his laboratory primarily involve studying the anticancer effects of OMD in cell culture, mouse models and human subjects. Other projects are focused on TRPMS stimulation using brain functional magnetic resonance imaging and electrophysiological approaches for application in basic neuroscience research and neuromodulatory therapies in neurobehavioral disorders. He is also interested in developing devices and methods inspired by theoretical ideas to conduct research related to neural processes underlying consciousness.
Visit website: https://www.houstonmethodist.org/faculty/santosh-helekar/
Details last updated 20-Nov-2023
Device uses non-invasive magnetic fields to increase ROS levels in cancer cells